P
Phenox
Dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of neurovascular diseases
About Phenox
Phenox, founded in 2005, specializes in developing innovative and clinically proven technologies for treating neurovascular diseases. The company serves endovascular specialists who treat ischemic and hemorrhagic strokes. Operating in the medical device market, Phenox offers a portfolio of advanced treatment options, including aneurysm implants and flow diverter coatings designed to reduce thrombosis risk. The business model revolves around the sale of these specialized medical devices, generating revenue through direct sales and partnerships. Phenox is committed to expanding its global reach, making its cutting-edge solutions accessible to more patients worldwide.
Source: Dealroom company dataAt a glance
- Founded
- 2005
- Headquarters
- Bochum, Germany
- Sector
- Biotech & Life Sciences
- Outcome tier
- Colt$25–100M revenue
Knowledge graph
News
More headlines
Open roles
Phenox in the Bochum ecosystem
The Phenox office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Phenox on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Phenox on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.